| Effects of sodium‐glucose cotransporter 2 inhibitors on 24‐hour ambulatory blood pressure: a systematic review and meta‐analysis WL Baker, LF Buckley, MS Kelly, JD Bucheit, ED Parod, R Brown, ... Journal of the American Heart Association 6 (5), e005686, 2017 | 186 | 2017 |
| Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease MS Kelly, J Lewis, AM Huntsberry, L Dea, I Portillo Postgraduate medicine 131 (1), 31-42, 2019 | 103 | 2019 |
| Effectiveness of pharmacist‐led amiodarone monitoring services on improving adherence to amiodarone monitoring recommendations: a systematic review DL Dixon, SP Dunn, MS Kelly, TR McLlarky, RE Brown Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (2 …, 2016 | 19 | 2016 |
| Effects of sodium–glucose cotransporter 2 inhibitors on 24-hour ambulatory blood Pressure: a systematic review and meta-analysis. J Am Heart Assoc. 2017 WL Baker, LF Buckley, MS Kelly, JD Bucheit, ED Parod, R Brown, ... Important summary of ABPM data and SGLT2 inhibitors-provides a balanced …, 0 | 17 | |
| PCSK9 inhibitors in secondary prevention—an opportunity for personalized therapy C Board, MS Kelly, MD Shapiro, DL Dixon Journal of cardiovascular pharmacology 75 (5), 410-420, 2020 | 12 | 2020 |
| Concordance of pharmacist assessment of medication nonadherence with a self-report medication adherence scale MS Kelly, LR Moczygemba, SS Gatewood Journal of Pharmacy Practice 29 (3), 194-198, 2016 | 12 | 2016 |
| Pharmacologic approaches for the management of patients with moderately elevated triglycerides (150–499 mg/dL) MS Kelly, C Beavers, JD Bucheit, EM Sisson, DL Dixon Journal of Clinical Lipidology 11 (4), 872-879, 2017 | 11 | 2017 |
| Pharmacist-led programs to increase statin prescribing: a narrative review of the literature M Elkomos, R Jahromi, MS Kelly Pharmacy 10 (1), 13, 2022 | 7 | 2022 |
| Home blood pressure monitoring to improve hypertension control: a narrative review of international guideline recommendations J Andraos, L Munjy, MS Kelly Blood Pressure 30 (4), 220-229, 2021 | 7 | 2021 |
| Evolving role of non-statin therapy for the management of dyslipidemia and cardiovascular risk reduction: past, present, and future EM Sisson, L Pamulapati, JD Bucheit, MS Kelly, DL Dixon | 7 | 2017 |
| Role of lipoprotein (a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies IS Alhomoud, A Talasaz, A Mehta, MS Kelly, EM Sisson, JD Bucheit, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43 (10 …, 2023 | 6 | 2023 |
| Effects of GLP-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: a systematic review and meta-analysis M Kelly, J Lewis, H Rao, J Carter, I Portillo, R Beuttler Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2022 | 6 | 2022 |
| Role of bempedoic acid in dyslipidemia management MS Kelly, EM Sulaica, CJ Beavers Journal of Cardiovascular Pharmacology 76 (4), 376-388, 2020 | 6 | 2020 |
| Assessment of achieved systolic blood pressure in newly treated hypertensive patients aged 60–79 years before and after Eighth Joint National Committee recommendations MS Kelly, JJ Saseen, JC Marrs Therapeutic Advances in Cardiovascular Disease 11 (2), 63-71, 2017 | 4 | 2017 |
| An update on dapagliflozin for chronic kidney disease. MS Kelly Drugs of Today (Barcelona, Spain: 1998) 58 (2), 69-75, 2022 | 2 | 2022 |
| With Current Safety and Efficacy Data, Should Statins Be Made Available as Nonprescription Over-the-Counter Drugs? A Mehta, DL Dixon, A Saeed, MS Kelly, M Gulati, MD Shapiro, ... Current cardiology reports 25 (5), 423-430, 2023 | 1 | 2023 |
| Efficacy and Safety of a polypill to reduce cardiovascular events: A review of clinical trials. MS Kelly, A Dacey, A Siana, J Ojeda Journal of Cardiovascular Pharmacology, 10.1097, 2022 | 1 | 2022 |
| KEY CONCEPTS DL Dixon, DM Riche, MS Kelly DiPiro's Pharmacotherapy: A Pathophysiologic Approach 3 (4), 121, 2023 | | 2023 |
| Inclisiran: A knight in shining armor? M Kelly, DL Dixon American Heart Hournal Plus: Cardiology Research and Practice 16, 2022 | | 2022 |
| An Overview of the ACC/AHA Recommendations on Cholesterol Management in People With Diabetes J Bucheit, MS Kelly ADCES in Practice 8 (2), 20-24, 2020 | | 2020 |
Dave L. DixonProfessor and Chair, Virginia Commonwealth University School of Pharmacyبريد إلكتروني تم التحقق منه على vcu.edu
